Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders

 
 

REGENERON PHARMACEUTICALS, INC. (REGN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $627.10 Metrics
OS: 108.6 M
Market cap: $68.1 B
Net cash: $13.3 B $122.26 per share
EV: $54.8 B

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues12,172.916,071.78,497.16,557.65,145.65,872.24,860.44,103.7
            Revenue growth-24.3%89.1%29.6%27.4%-12.4%20.8%18.4%45.5%
Cost of goods sold1,560.42,437.51,119.9765.1237.5397.1299.7241.7
Gross profit10,612.513,634.27,377.25,792.54,908.15,475.14,560.73,862.0
            Gross margin87.2%84.8%86.8%88.3%95.4%93.2%93.8%94.1%
Selling, general and administrative2,115.91,824.91,346.01,341.91,127.21,320.41,177.7838.5
Research and development3,592.52,860.12,647.02,450.01,468.82,075.12,052.31,620.6
EBIT4,994.08,994.83,664.62,209.82,534.42,079.61,330.71,251.9
            EBIT margin41.0%56.0%43.1%33.7%49.3%35.4%27.4%30.5%
Pre-tax income4,858.89,325.83,810.42,429.12,553.52,078.51,329.81,225.1
Income taxes520.41,250.5297.2313.3109.1880.0434.3589.0
            Tax rate10.7%13.4%7.8%12.9%4.3%42.3%32.7%48.1%
Net income4,338.48,075.33,513.22,115.82,444.41,198.5895.5636.1
            Net margin35.6%50.2%41.3%32.3%47.5%20.4%18.4%15.5%
 
Diluted EPS$38.22$71.97$30.52$18.46$21.29$10.34$7.70$5.52
Shares outstanding (diluted)113.5112.2115.1114.6114.8115.9116.3115.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy